Eye-Tracking test may spot vestibular migraine
NCT ID NCT07000929
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether videonystagmography (VNG) with caloric testing, a standard balance exam, can distinguish people with vestibular migraine from those with other migraines and healthy individuals. Researchers compared eye movement patterns in 173 participants across three groups. The goal was to see if VNG could become a reliable diagnostic tool for this often-misdiagnosed condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a reliable diagnostic test for vestibular migraine, helping doctors identify the condition more accurately.
- What could go wrong
- This is a completed diagnostic study, not a treatment trial. The test may not prove accurate enough for routine clinical use, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Westdeutsches Kopfschmerz und Schwindelzentrum der Klinik für Neurologie des Universitätklinikums Essen
Essen, North Rhine-Westphalia, 45147, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted botox shot quiet the Brain's pain center for chronic migraine?
- Could a symptom registry unmask hidden migraine variants?
- Melatonin may double up against childhood migraines
- Online sleep therapy may ease migraines in teens
- Scientists aim to forecast migraine pain using wearable sensors and early symptoms
- Migraine drug AJOVY under Real-World safety spotlight